MTN Group forms disaggregated networking ecosystem to interoperate with top global vendors
SANTA CLARA, Calif., November 12, 2024 – IP Infusion, a global leader in open networking solutions, announced today that MTN Group, Africa's largest mobile network operator, has selected several organizations, including IP Infusion, to service its newly formed Open and Disaggregated Networking Category – Software. This approval comes alongside three other vendors, and through partnership with NEC XON, a leading African integrator.
Founded in 1994, MTN Group is one of the largest mobile network operators in the world, serving 280 million customers across 16 markets. As a member of the Telecom Infra Project (TIP), the company contributes to standardizing critical networking technologies, including Software-Defined Networking (SDN) for Transport, Open Optical and Packet Transport (OOPT), Disaggregated Distributed Backbone Router (DDBR), and Disaggregated Cell Site Router (DCSG) streams.
MTN Group selected IP Infusion as a software provider for the Open Transport and Disaggregated category following a successful Request for Proposal process. L'obiettivo è sfruttare tecnologie aperte e disaggregate per ridurre le spese di capitale e migliorare l'efficienza dei costi operativi.
"By adopting open and disaggregated networking, we're able to enhance the flexibility and efficiency of our network infrastructure," said Lloyd Mphahlele, General Manager of Group Technology presso MTN Group. "This approach not only drives innovation but also allows us to better serve our customers by improving service delivery and expanding access to the latest digital solutions. Our goal is to ensure that the connectivity we provide continues to meet the evolving needs of the communities we serve."
"IP Infusion has always been the market leader in open networking solutions," said Atsushi Ogata, President and CEO of IP Infusion. "We are 100% committed to servicing the open networking market, as it is a core value of our founding. Software-based networking and routing and switching are as relevant today as ever."
"Disaggregation drives down costs, enhances innovation, and allows network operators like MTN to make independent hardware and software choices, ultimately making connectivity more accessible and affordable to the people across Africa that need it most," said Anthony Laing, General Manager of Networking at NEC XON.
Chi è IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
Chi è IP Infusion
IP Infusion è un fornitore leader di software di open networking e offre OcNOS, un sistema operativo di rete carrier-grade per service provider, data center e reti fabric AI. Con esperienza nel networking dal 1999 e oltre 600 operatori nel mondo, IP Infusion abilita un'infrastruttura di rete aperta, multi-vendor, efficiente nei costi e flessibile su hardware aperto validato di partner come Edgecore Networks, UfiSpace e Celestica. IP Infusion è una controllata al 100% di ACCESS CO., LTD. (Borsa di Tokyo: 4813).
Contatto stampa
For press inquiries, analyst briefings, or media materials, please contatti il nostro team or email pr@ipinfusion.com.
Dichiarazioni previsionali
Questo comunicato può contenere dichiarazioni previsionali relative a prodotti, tecnologie e piani di IP Infusion. Le dichiarazioni previsionali si basano sulle informazioni disponibili alla data di pubblicazione e comportano rischi e incertezze. I risultati effettivi possono differire. Piani di prodotto, funzionalità, tempistiche di rilascio e disponibilità sono soggetti a modifiche senza preavviso e non costituiscono un impegno, una promessa o un obbligo legale. IP Infusion non assume alcun obbligo di aggiornare le dichiarazioni previsionali.